|
Delayed
Canadian Securities Exchange
15:33:05 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 0.0100 CAD | 0.00% |
|
0.00% | -20.00% |
| Market Cap | 5.21M 3.78M 3.25M 3.05M 2.79M 357M 5.25M 36.08M 14.05M 182M 14.18M 13.87M 588M | P/E 2024 |
-4.18x | P/E 2025 | -22.7x |
|---|---|---|---|---|---|
| Enterprise Value | 22.27M 16.15M 13.89M 13.04M 11.93M 1.53B 22.44M 154M 60.07M 780M 60.64M 59.32M 2.51B | EV / Sales 2024 |
1.1x | EV / Sales 2025 | 1.26x |
| Free-Float |
86.8% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| QF | Delayed | |
OTC Markets
| TGIFF | Delayed |
| 3 months | +100.00% | ||
| Current year | -20.00% |
| 1 week | 0 | 0.02 | |
| 1 month | 0 | 0.02 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.02 | |
| 3 years | 0 | 0.03 | |
| 5 years | 0 | 0.09 | |
| 10 years | 0 | 1.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Farrell
CEO | Chief Executive Officer | - | 2025-01-31 |
Jeremy Fong
DFI | Director of Finance/CFO | 34 | 2025-01-31 |
Ester Vigil
PSD | President | - | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Brian Farrell
CHM | Chairman | - | 2025-01-31 |
Paul Rosen
CHM | Chairman | 62 | 2021-01-28 |
Curtis Floyd
BRD | Director/Board Member | - | 2023-06-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/1/25 | Option | Company Secretary | 100,000 | 0.0204% | ||
| 12/1/25 | Option | Investor Relations Manager | 200,000 | 0.0408% | ||
| 9/22/25 | Buy | Chief Executive Officer | 2,000,000 | 0.4078% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | -50.00% | 3.76M | ||
| -4.84% | +1.39% | +15.22% | -26.96% | 2.65B | ||
| +2.10% | +8.16% | +59.07% | +84.96% | 2.25B | ||
| 0.00% | +2.19% | +5.74% | +84.07% | 526M | ||
| 0.00% | -7.02% | -10.17% | -11.67% | 58.51M | ||
| Average | -0.55% | +0.40% | +13.97% | +16.08% | 1.1B | |
| Weighted average by Cap. | -1.47% | +3.50% | +32.02% | +29.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 19.35M 14.03M 12.08M 11.33M 10.37M 1.33B 19.5M 134M 52.21M 678M 52.7M 51.55M 2.18B | 17.45M 12.65M 10.89M 10.22M 9.35M 1.2B 17.59M 121M 47.07M 611M 47.52M 46.48M 1.97B |
| Net income | -1.14M -828K -713K -669K -612K -78.3M -1.15M -7.91M -3.08M -40.01M -3.11M -3.04M -129M | -217K -157K -135K -127K -116K -14.88M -219K -1.5M -586K -7.6M -591K -578K -24.49M |
| Net Debt | 16.33M 11.84M 10.19M 9.56M 8.75M 1.12B 16.46M 113M 44.05M 572M 44.47M 43.5M 1.84B | 17.06M 12.37M 10.64M 9.99M 9.14M 1.17B 17.19M 118M 46.02M 598M 46.46M 45.45M 1.92B |
Employees
85
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-02 | $0.0100 | 0.00% | 55,000 |
| 26-09-01 | $0.0100 | 0.00% | 21,500 |
| 26-08-31 | $0.0100 | 0.00% | 49,333 |
| 26-08-28 | $0.0100 | +100.00% | 102,000 |
| 26-08-27 | $0.005000 | -50.00% | 11,500 |
- Stock Market
- Stocks
- QF Stock
Select your edition
All financial news and data tailored to specific country editions

















